Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Avastin No Longer Approved for Breast Cancer, FDA SaysAvastin No Longer Approved for Breast Cancer,
Link ID 38339
Title Avastin No Longer Approved for Breast Cancer, FDA SaysAvastin No Longer Approved for Breast Cancer,
Url http://www.medscape.com/viewarticle/753862?src=rsshttp://www.medscape.com/viewarticle/753862?src=rss
Description "Patients must have confidence that the drugs they take are both safe and effective for their intended use," says FDA Commissioner Margaret Hamburg, MD. News Alerts
Category Articles > Hematology-Oncology
Keywords
Date Nov 19, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Bevacizumab for Breast Cancer Hotly Debated
  Over the past week, as an FDA decision is awaited, a flurry of media reports has led to a debate about the use of bevacizumab in breast cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Major Clinical Advances in Cancer in 2011Major Clinical Advances in Cancer in 2011
  Twelve major clinical advances and another 42 notable advances are highlighted this year by the American Society of Clinical Oncology. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. HPV Vaccine Policy: At Odds With Evidence-Based Medicine?HPV Vaccine Policy: At Odds With Evidence-B
  According to a new study, there is a major discrepancy in claims regarding the safety and efficacy of the human papillomavirus (HPV) vaccines. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Ruxolitinib in Myelofibrosis: Only for Some Patients Ruxolitinib in Myelofibrosis: Only for Some Pat
  The first drug ever approved for use in myelofibrosis might only be useful in some patients with this disorder; even then, it might not be the best option. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Rash Prediction in Lung Cancer?
  Dr. Maurie Markman discusses a provocative study indicating that the development of a rash may predict effectiveness of rituximab in patients with non-small cell lung cancer. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS